Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other
pharmaceutical manufacturers in Asia:
Unichem Laboratories Limited
sales of 15.20 billion Indian Rupees [US$237.04 million]
of which 100%
Daito Pharmaceutical Company Limited
(37.98 billion Japanese Yen [US$349.08 million]
Kissei Pharmaceutical Company Limited
(71.71 billion Japanese Yen [US$658.98 million]
of which 86%
was Pharmaceutical Products).
Hisamitsu Pharmaceutical Co Inc reported sales of ¥145.93 billion (US$1.34 billion)
February of 2017.
decrease of 9.8%
versus 2016, when the company's sales were ¥161.85 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Hisamitsu Pharmaceutical Co Inc had sales
of ¥137.79 billion.